We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$74.5M
AUM Growth
-$16.5M
Cap. Flow
-$10M
Cap. Flow %
-13.49%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
2
Reduced
4
Closed
3

Sector Composition

Rank Sector Weight
1 Materials 32.61%
2 Healthcare 23.09%
3 Energy 20.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$16.7M 22.44%
+50,000
New +$16.6M
NEM icon
2
Newmont
NEM
$124B
$15.9M 21.29%
250,000
-100,000
-29% -$6.52M
RETA
3
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14.6M 19.62%
150,000
-51,000
-25% -$6.37M
NVGS icon
4
Navigator Holdings
NVGS
$1.26B
$11.4M 15.32%
1,365,000
+47,099
+4% +$392K
B
5
Barrick Mining
B
$67.9B
$8.43M 11.32%
300,000
-200,000
-40% -$5.7M
EPSN icon
6
Epsilon Energy
EPSN
$180M
$3.89M 5.22%
1,283,245
+198,245
+18% +$616K
IRIX icon
7
IRIDEX
IRIX
$15.1M
$2.59M 3.47%
1,320,000
ESXB
8
DELISTED
Community Bankers Trust Corporation
ESXB
$983K 1.32%
193,587
-56,413
-23% -$286K
ABBV icon
9
AbbVie
ABBV
$440B
-60,000
Closed -$5.89M
CI icon
10
Cigna
CI
$73.3B
-10,000
Closed -$1.88M
PARR icon
11
Par Pacific Holdings
PARR
$3.9B
-110,000
Closed -$989K

Similar funds

Paragon Associates & Paragon Associates II Joint Venture's Q3 2020 Portfolio in Review

As of Q3 2020, Paragon Associates & Paragon Associates II Joint Venture held 11 positions worth $74.5M, down 18% from $91M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture withdrew a net $10M in Q3 2020, closing 3 positions and reducing 4 holdings. Its most notable exit was AbbVie, an estimated $5.89M position sold in full.

By sector, the portfolio is most concentrated in Materials at 33% of assets, down from 39% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Paragon Associates & Paragon Associates II Joint Venture opened a new position in State Street SPDR S&P 500 ETF Trust worth $16.7M.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 50,000 shares worth $16.7M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Epsilon Energy in Q3 2020, an estimated $616K increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q3 2020 reduction was Newmont, cutting an estimated $6.52M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited AbbVie in Q3 2020, selling an estimated $5.89M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 100% of its $74.5M portfolio in Q3 2020.
  • Paragon Associates & Paragon Associates II Joint Venture opened 1 new position and closed 3 in Q3 2020.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 18% quarter-over-quarter to $74.5M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q3 2020, filed 13 Nov 2020.